Bolt Biotherapeutics, Inc. (BOLT)
5.44
-0.42
(-7.17%)
USD |
NASDAQ |
Dec 12, 16:00
5.41
-0.03
(-0.55%)
After-Hours: 20:00
Bolt Biotherapeutics Shareholders Equity (Quarterly): 32.10M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 94.87M |
| Protagonist Therapeutics, Inc. | 645.44M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 65.05M |
| Total Liabilities (Quarterly) | 32.95M |
| Debt to Equity Ratio | 0.7348 |
| Current Ratio | 3.573 |
| Net Debt Paydown Yield | -9.21% |